Guest post: Redefining cancer may change the orphan status of cancer drugs

      *This post was originally posted on the Context Matters blog* Context Matters will be exhibiting at Evidence USA this October in Boston.  Join us at America's largest and most holistic event on the use of real world outcomes for pharmaceutical products.   A recent NY Times piece by Tara Parker-Pope reported on the recommendation by a group …

Ebook: Top 20 Big Data projects in Pharma & Biotech – Part 2

    There are 5 main areas of Big Data investigation in real world outcomes by pharma today… Remote, mobile health – The use of mobile devices such as smart phones to gather data on treatment adherence, on-going patient care, predictive symptoms or adverse events and health outcomes Healthcare provider data – Collecting data from electronic medical records that includes …